Literature DB >> 31722639

A modified Terrono classification for Type 1 thumb deformity in rheumatoid arthritis: a cross-sectional analysis.

Shogo Toyama1,2,3, Ryo Oda1, Maki Asada1, Satoru Nakamura1, Masato Ohara1, Daisaku Tokunaga1, Yasuo Mikami3.   

Abstract

The most common thumb deformity in rheumatoid arthritis is Nalebuff Type 1 deformity (boutonniere deformity). Type 1 deformity severely impairs hand function, and this impairment is evaluated by the Terrono classification. In some cases, the Terrono classification incorrectly categorizes advanced thumb deformity into earlier stages. We modified the Terrono classification by assessing the active range of motion of the interphalangeal joint prior to assessing the passive range of movement of the metacarpophalangeal joint. An active range of movement of the interphalangeal joint was strongly correlated with hand function. In 55 hands that we treated between 2004 and 2015, we compared the modified classification with the original Terrono classification. Our modified classification could detect advanced deformity earlier, and was more strongly correlated with hand function. Additionally, correlation analysis showed that advanced Type 1 deformity should be treated first, even in cases with severe ulnar drift. Our results suggest that the modified classification may benefit the treatment of Type 1 deformity, including joint-preserving surgery. Level of evidence: III.

Entities:  

Keywords:  Rheumatoid arthritis; Terrono classification; Type 1; boutonniere deformity; thumb; ulnar drift

Mesh:

Year:  2019        PMID: 31722639     DOI: 10.1177/1753193419886719

Source DB:  PubMed          Journal:  J Hand Surg Eur Vol        ISSN: 0266-7681


  1 in total

1.  Comprehensive assessment of alterations in hand deformities over 11 years in patients with rheumatoid arthritis using cluster analysis and analysis of covariance.

Authors:  Shogo Toyama; Daisaku Tokunaga; Shinji Tsuchida; Rie Kushida; Ryo Oda; Yutaka Kawahito; Kenji Takahashi
Journal:  Arthritis Res Ther       Date:  2021-02-27       Impact factor: 5.156

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.